IRIS
TOSCANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.197
NA - Nord America 15.689
AS - Asia 10.898
SA - Sud America 3.719
AF - Africa 315
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 48.837
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.365
RU - Federazione Russa 9.623
SG - Singapore 4.658
BR - Brasile 3.166
CN - Cina 3.025
IE - Irlanda 2.398
SE - Svezia 1.603
HK - Hong Kong 1.246
IT - Italia 1.119
DE - Germania 767
VN - Vietnam 602
FR - Francia 555
UA - Ucraina 524
FI - Finlandia 469
PL - Polonia 379
IN - India 327
GB - Regno Unito 303
AR - Argentina 182
BD - Bangladesh 145
CA - Canada 133
MX - Messico 109
TR - Turchia 106
NL - Olanda 103
ID - Indonesia 93
ZA - Sudafrica 93
EC - Ecuador 92
IQ - Iraq 87
JP - Giappone 81
BE - Belgio 76
AT - Austria 72
CO - Colombia 71
PK - Pakistan 67
VE - Venezuela 64
MA - Marocco 56
UZ - Uzbekistan 55
PY - Paraguay 51
TH - Thailandia 49
ES - Italia 41
CL - Cile 36
KE - Kenya 34
TN - Tunisia 32
JO - Giordania 28
PE - Perù 28
PH - Filippine 28
IR - Iran 26
KZ - Kazakistan 26
SA - Arabia Saudita 26
LT - Lituania 25
IL - Israele 24
AZ - Azerbaigian 23
CI - Costa d'Avorio 23
CZ - Repubblica Ceca 22
AE - Emirati Arabi Uniti 20
EG - Egitto 20
DZ - Algeria 19
MY - Malesia 19
NP - Nepal 19
JM - Giamaica 18
OM - Oman 18
DO - Repubblica Dominicana 17
LB - Libano 17
UY - Uruguay 16
AL - Albania 13
HR - Croazia 13
KR - Corea 12
BO - Bolivia 11
KG - Kirghizistan 11
RS - Serbia 11
CR - Costa Rica 10
HN - Honduras 9
RO - Romania 9
AU - Australia 8
CH - Svizzera 8
PA - Panama 8
ET - Etiopia 7
GR - Grecia 7
GT - Guatemala 7
PS - Palestinian Territory 7
PT - Portogallo 7
SN - Senegal 7
AM - Armenia 6
BG - Bulgaria 6
DK - Danimarca 6
EU - Europa 6
LV - Lettonia 6
QA - Qatar 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
GA - Gabon 5
HU - Ungheria 5
KW - Kuwait 5
LK - Sri Lanka 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
AO - Angola 4
BH - Bahrain 4
KH - Cambogia 4
MN - Mongolia 4
CY - Cipro 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 48.782
Salva come PNG Salva come JPEG
Città #
Moscow 3.029
Ashburn 2.409
Dublin 2.396
Singapore 2.237
Dallas 2.137
Chandler 1.479
Hong Kong 1.246
Jacksonville 1.145
Nyköping 1.023
Beijing 948
San Jose 561
The Dalles 556
Princeton 440
Los Angeles 407
Medford 406
Messina 395
Lauterbourg 384
Warsaw 368
Cambridge 333
Des Moines 314
Dearborn 308
Ann Arbor 286
New York 259
São Paulo 236
Buffalo 193
Ho Chi Minh City 193
Munich 175
Wilmington 149
Tianjin 145
Boardman 139
Jinan 117
Guangzhou 116
Hanoi 116
San Mateo 113
Shenyang 107
Redondo Beach 104
Frankfurt am Main 99
Orem 99
Rio de Janeiro 93
Council Bluffs 89
Nanjing 82
Belo Horizonte 77
Rome 75
Tokyo 72
Hyderabad 71
Turku 71
Santa Clara 69
Ningbo 67
Houston 66
Chennai 61
Helsinki 61
Brasília 58
Brooklyn 58
Nuremberg 57
Zhengzhou 55
Woodbridge 53
Hebei 52
Brussels 51
Bremen 49
Curitiba 49
Johannesburg 49
San Francisco 48
Denver 47
Hangzhou 47
Seattle 47
Tashkent 47
Amsterdam 46
Shanghai 46
Shenzhen 46
Atlanta 44
Falls Church 42
Jakarta 42
Pune 42
Bangkok 41
Milan 41
Vienna 41
Campinas 40
Taizhou 40
Lancaster 38
Dong Ket 36
London 36
Montreal 36
Porto Alegre 36
Guayaquil 35
Catania 34
Stockholm 34
Haikou 32
Mexico City 32
Nairobi 32
Salvador 32
Chicago 31
Mumbai 31
Boston 29
Fortaleza 29
Fuzhou 29
Manaus 29
Nanchang 29
Quito 29
Amman 28
Ankara 28
Totale 28.104
Salva come PNG Salva come JPEG
Nome #
The relationship between sleep quality and ratio of house size/number of people in chronic migraineurs during Covid-19 lockdown. 303
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 284
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 255
Clinical and pathological features of focal myositis 248
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 248
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 245
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 218
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 215
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 208
A cytochemical study of apoptosis in metabolic myopathies 206
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 205
Atypical posterior reversible encephalopathy syndrome with hemispheric brainstem and spinal cord involvement in a patient with acute kidney injury – a case report. 204
A life threatening case of β-enolase deficiency 200
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 198
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 197
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 193
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 190
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 189
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 189
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 188
Auditory system involvement study in 20 patients with late-onset Pompe disease 186
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 185
Community-acquired enterococcal meningitis caused by Enterococcus casseliflavus: first case report 184
Pimozide and pancreatic cancer in diabetic chorea: a case report 181
A benign case of congenital myotonic dystrophy 180
Variants of the circle of Willis in ischemic stroke patients 179
A case of vacuolar myopathy during the course of chronic hepatitis C. 176
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 176
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 175
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 175
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 175
ANT1 is reduced in sporadic inclusion body myositis. 175
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 173
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 173
A genetic modifier of symptom onset in Pompe disease 173
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 172
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 170
Analysis of lipid profile in lipid storage myopathy 169
Ischemic stroke and reperfusion therapies in diabetic patients 169
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 168
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 168
A novel Cx32 mutation with unusual phenotype. 167
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 166
A study of auditory system in 20 patients with late onset Pompe disease 166
211th ENMC International Workshop:: Development of diagnostic criteria and management strategies for McArdle Disease and related rare glycogenolytic disorders to improve standards of care. 17–19 April 2015, Naarden, The Netherlands 166
Apoptosis and apoptosis-related proteins in thyroid myopathies 164
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 164
Isolated Insular Stroke: Clinical Presentation 164
Autoimmune juvenile limb-girdle myasthenia 164
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 163
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 163
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 163
Management of Teenage Stroke in the Acute Setting: Two Case Reports 163
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 162
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 160
Deficit multiplo di Acyl-CoA deidrogenasi responsivo alla riboflavina (MADD-RR): studio clinico, biochimico, genetico e spettroscopico 158
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 158
Enterococcal meningitis caused by Enterococcus casseliflavus. First case report. 157
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 157
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 157
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 156
Chronic migraine in the first COVID‐19 lockdown: the impact of sleep, remote working, and other life/psychological changes 156
Auditory system involvement study in 20 patients with lateonset pompe disease 155
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 155
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 153
A novel mithocondrial tRNAHys point mutation in a patient with PSP-like phenotype. 153
Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection. 153
Primary CNS infiltrative parenchymal histiocytosis 153
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 152
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 152
Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum 152
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 151
Fatal R631C mutation is also present in the adult form of CPTII deficiency 150
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 150
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 149
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 149
Acute ischemic stroke due to endocarditis from Brucella infection 149
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 149
208th ENMC International Workshop: Formation of a European Network to develop a European data sharing model and treatment guidelines for Pompe disease. 148
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 147
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 147
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 147
Miopatie metaboliche 146
Severe rhabdomyolysis in a patient with “Heat Stroke” 146
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 145
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 145
Recurrent intracranial hemorrhage and cerebral venous sinus thrombosis: an atypical case of Neuro-Behçet’s Syndrome 145
Minor stroke with bilateral acute infarctions and combined vascular anomalies: A complex case report 144
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 144
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07) 143
Are there ERT defined guidelines for Pompe disease? 143
Repeated reperfusion treatment in recurrent ischemic stroke: A retrospective single-center case series 143
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 142
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 142
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease 141
Endocrine myopathies: Clinical and histopathological features of the major forms 141
An unusual association of dominant optic atrophy with OPA1 mutations and parkinsonian syndrome. 140
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 140
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG. 140
MuSK-Associated Myasthenia Gravis: Clinical Features and Management 140
Totale 17.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021575 0 0 0 0 0 0 0 0 0 323 170 82
2021/20222.607 19 330 27 133 139 40 241 118 58 203 318 981
2022/20236.263 549 519 299 406 413 586 87 347 2.802 23 168 64
2023/20241.757 136 246 137 138 123 356 22 173 14 152 48 212
2024/20258.635 140 74 134 526 390 303 229 1.594 2.176 475 958 1.636
2025/202624.179 1.134 1.782 2.236 1.841 1.960 5.167 3.041 2.948 3.046 1.024 0 0
Totale 49.802